Our results indicated that knockdown of UBE2C decreased the expression levels of these cancer stemness markers including ALDH1A2, CD44, CD166 and EpCAM in both Ca9-22 and SAS cells (Figure 4). This evidence concerns the gene CD44 and cancer.